Tvardi Therapeutics, Inc. (TVRD)
1.82
+0.02
(+1.11%)
USD |
NASDAQ |
Aug 28, 16:00
1.81
-0.01
(-0.55%)
After-Hours: 20:00
Tvardi Therapeutics Shareholders Equity (Quarterly) : 8.382M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.382M |
| March 31, 2026 | 14.50M |
| December 31, 2025 | 20.95M |
| September 30, 2025 | 27.87M |
| June 30, 2025 | 32.93M |
| March 31, 2025 | -8.073M |
| December 31, 2024 | -5.628M |
| September 30, 2024 | 0.707M |
| June 30, 2024 | 11.60M |
| March 31, 2024 | 29.80M |
| December 31, 2023 | 57.08M |
| September 30, 2023 | 85.64M |
| June 30, 2023 | 108.93M |
| March 31, 2023 | 136.60M |
| December 31, 2022 | 158.78M |
| September 30, 2022 | 184.82M |
| June 30, 2022 | 204.42M |
| March 31, 2022 | 204.12M |
| December 31, 2021 | 227.52M |
| September 30, 2021 | 252.16M |
| June 30, 2021 | 203.47M |
| March 31, 2021 | 230.46M |
| December 31, 2020 | 249.00M |
| September 30, 2020 | 127.85M |
| June 30, 2020 | 140.93M |
| Date | Value |
|---|---|
| March 31, 2020 | 160.47M |
| December 31, 2019 | 186.71M |
| September 30, 2019 | 211.89M |
| June 30, 2019 | 99.54M |
| March 31, 2019 | 114.52M |
| December 31, 2018 | 133.63M |
| September 30, 2018 | 149.53M |
| June 30, 2018 | 73.08M |
| March 31, 2018 | 72.10M |
| December 31, 2017 | 86.78M |
| September 30, 2017 | 99.07M |
| June 30, 2017 | 109.22M |
| March 31, 2017 | 115.79M |
| December 31, 2016 | 50.72M |
| September 30, 2016 | 71.80M |
| June 30, 2016 | 82.59M |
| March 31, 2016 | 94.93M |
| December 31, 2015 | 105.04M |
| September 30, 2015 | 113.86M |
| June 30, 2015 | 42.47M |
| March 31, 2015 | 47.42M |
| December 31, 2014 | 51.66M |
| September 30, 2014 | 55.34M |
| June 30, 2014 | 61.57M |
| March 31, 2014 | 64.73M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 33.88B |
| Crinetics Pharmaceuticals, Inc. | 1.192B |
| Liquidia Corp. | 195.11M |
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 17.52M |
| Total Liabilities (Quarterly) | 9.135M |
| Debt to Equity Ratio | 0.0173 |
| Current Ratio | 1.873 |
| Net Debt Paydown Yield | 51.25% |